Mapping Key Clinical Trial Eligibility Criteria (EC) to Real-world Data (RWD): An Example Using KENYOTE-48

被引：0
作者：
Zheng, D. [1 ]
Jemielita, T. [1 ]
Ai, L. [1 ]
Black, C. M. [1 ]
Hair, G. M. [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
155
引用
收藏
页码：E39 / E39
页数：1
相关论文
共 50 条
[31]   MAPPING REAL-WORD ANKYLOSING SPONDYLITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA [J].
Sholter, Dalton ;
Inman, Robert ;
Masetto, Ariel ;
Rahman, Proton ;
Rampakakis, Emmanouil ;
Asin-Milan, Odalis ;
Rachich, Meagan ;
Nantel, Francois ;
Lehman, Allen J. .
INTERNAL MEDICINE JOURNAL, 2020, 50 :9-10
[32]   MAPPING REAL-WORD RHEUMATOID ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA [J].
Keystone, Ed ;
Olsynski, Wojciech ;
Bessette, Louis ;
Rahman, Proton ;
Rampakakis, Emmanouil ;
Lehman, Allen J. ;
Asin-Milan, Odalis ;
Nantel, Francois ;
Rachich, Meagan .
INTERNAL MEDICINE JOURNAL, 2020, 50 :10-10
[33]   Modeling Diversity in Systemic Lupus Erythematosus (SLE) Clinical Trials Using Real-world Data (RWD) Sources [J].
Bevan, Andrew ;
Carroll, Nora .
ARTHRITIS & RHEUMATOLOGY, 2024, 76 :2859-2860
[34]   Demonstrating Differences Between Clinical Trial Data and Real-World Data (RWD) in Metastatic Castration-Resistant Prostate Cancer (mCRPC) [J].
Pillai, Sruti ;
Semira, Christine ;
Pezaro, Carmel ;
Parente, Phillip ;
Tran, Ben .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 :135-135
[35]   Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation [J].
Lee, Kyeryoung ;
Liu, Zongzhi ;
Mai, Yun ;
Jun, Tomi ;
Ma, Meng ;
Wang, Tongyu ;
Ai, Lei ;
Calay, Ediz ;
Oh, William ;
Stolovitzky, Gustavo ;
Schadt, Eric ;
Wang, Xiaoyan .
JMIR AI, 2024, 3
[36]   Economic Evaluation of Cancer Drugs using Clinical Trial and Real-World Data [J].
Shanmugam, Ramalingam .
JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION, 2021, 91 (09) :1908-1909
[37]   Regulatory-grade clinical trial design using real-world data [J].
Levenson, Mark S. .
CLINICAL TRIALS, 2020, 17 (04) :377-382
[38]   BENEFITS AND CHALLENGES OF DETERMINISTIC, PROBABILISTIC, AND PATIENT-MEDIATED APPROACHES TO LINKING PATIENTS' CLINICAL TRIAL DATA (CTD) AND THEIR REAL-WORLD DATA (RWD) [J].
Zabell, T. ;
Jeswani, N. ;
Hahn, K. ;
Coutcher, J. ;
Papsch, R. .
VALUE IN HEALTH, 2022, 25 (12) :S476-S476
[39]   Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting [J].
Bennedsen, Tine Litske ;
Simonsen, Mikkel Runason ;
Jensen, Paw ;
Brown, Peter ;
Josefsson, Paer ;
Khurana, Arushi ;
Maurer, Matthew ;
Clausen, Michael Roost ;
Dessau-Arp, Andriette ;
Jorgensen, Jennifer Bogh ;
Jorgensen, Judit ;
Larsen, Thomas Stauffer ;
Pedersen, Lars Moller ;
Jakobsen, Lasse Hjort ;
El-Galaly, Tarec Christoffer .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (05) :832-839
[40]   Representativeness in clinical trial planning: An epidemiologic examination of race and ethnicity leveraging multiple real-world data (RWD) sources in the United States [J].
Bratton, Emily W. ;
Denarie, Michel ;
Stolper, Robert ;
Goins, Monica ;
Gemmen, Eric .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 :318-318
12345